<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">phkinetica</journal-id><journal-title-group><journal-title xml:lang="ru">Фармакокинетика и Фармакодинамика</journal-title><trans-title-group xml:lang="en"><trans-title>Pharmacokinetics and Pharmacodynamics</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2587-7836</issn><issn pub-type="epub">2686-8830</issn><publisher><publisher-name>ООО «Издательство ОКИ»</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.37489/2587-7836-2025-3-21-29</article-id><article-id custom-type="edn" pub-id-type="custom">MMTWCX</article-id><article-id custom-type="elpub" pub-id-type="custom">phkinetica-471</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>МЕХАНИЗМ ДЕЙСТВИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>MECHANISM OF ACTION</subject></subj-group></article-categories><title-group><article-title>Оценка препаратов рубрикатора АТХ методом хемореактомного скрининга для профилактики дефицитов магния и пиридоксина</article-title><trans-title-group xml:lang="en"><trans-title>Evaluation of ATX rubricator drugs by chemoreactome screening method for prevention of magnesium and pyridoxine deficiencies</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2659-7998</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Торшин</surname><given-names>И. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Torshin</surname><given-names>I. Yu.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Торшин Иван Юрьевич — к.ф–м.н., к.х.н., в.н.с. </p><p>Москва</p></bio><bio xml:lang="en"><p>Ivan Yu. Torshin — PhD, Cand. Sci. (Physics and Mathematics), Cand. Sci. (Chemistry), Leading researcher </p><p>Moscow</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6144-5781</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Калачева</surname><given-names>А. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Kalacheva</surname><given-names>A. G.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Калачева Алла Геннадьевна — к.м.н., доцент кафедры фармакологии </p><p>Иваново</p></bio><bio xml:lang="en"><p>Alla G. Kalacheva — PhD, Cand. Sci. (Med.), Associate Professor of the Department of Pharmacology </p><p>Ivanovo</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7663-710X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Громова</surname><given-names>О. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Gromova</surname><given-names>O. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Громова Ольга Алексеевна — профессор кафедры фармакологии ФГБОУ ВО Ивановский ГМУ Минздрава России; д.м.н, профессор, в.н.с. ФИЦ ИУ РАН</p><p>Иваново, Москва</p></bio><bio xml:lang="en"><p>Olga A. Gromova — Professor of the Department of Pharmacology FSBEI HE «Ivanovo SMU» of MOH of Russia; PhD, Dr. Sci. (Med.), Professor, Leading researcher FRC CSC RAS</p><p>Ivanovo, Moscow</p></bio><email xlink:type="simple">unesco.gromova@gmail.com</email><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0007-2744-4268</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Рогозин</surname><given-names>М. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Rogozin</surname><given-names>M. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Рогозин Михаил Александрович — аспирант кафедры фармакологии</p><p>Иваново</p></bio><bio xml:lang="en"><p>Mikhail A. Rogozin — Postgraduate student of the Department of Pharmacology</p><p>Ivanovo</p></bio><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГУ «Федеральный исследовательский центр «Информатика и управление» РАН» (ФИЦ ИУ РАН)</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Federal Research Center “Computer Science and Control”, RAS</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ФГБОУ ВО «Ивановский государственный медицинский университет» Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Ivanovo State Medical University of MOH of Russia</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>ФГУ «Федеральный исследовательский центр «Информатика и управление» РАН» (ФИЦ ИУ РАН);&#13;
ФГБОУ ВО «Ивановский государственный медицинский университет» Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Federal Research Center “Computer Science and Control”, RAS;&#13;
Ivanovo State Medical University of MOH of Russia</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2025</year></pub-date><pub-date pub-type="epub"><day>26</day><month>12</month><year>2025</year></pub-date><volume>0</volume><issue>3</issue><fpage>21</fpage><lpage>29</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Торшин И.Ю., Калачева А.Г., Громова О.А., Рогозин М.А., 2025</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="ru">Торшин И.Ю., Калачева А.Г., Громова О.А., Рогозин М.А.</copyright-holder><copyright-holder xml:lang="en">Torshin I.Y., Kalacheva A.G., Gromova O.A., Rogozin M.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.pharmacokinetica.ru/jour/article/view/471">https://www.pharmacokinetica.ru/jour/article/view/471</self-uri><abstract><sec><title>Актуальность</title><p>Актуальность. Лекарственные препараты могут приводить к потери организмом магния и пиридоксина (витамин В6), что ведёт к формированию побочных эффектов и ухудшает течение основного заболевания.</p></sec><sec><title>Цель</title><p>Цель. Оценка антимикронутриентного действия всех препаратов рубрикатора АТХ методами хемореактомного скрининга.</p></sec><sec><title>Материалы и методы</title><p>Материалы и методы. Методами топологического анализа данных и анализа размеченных графов проведён систематический компьютерный анализ баз данных (SIDER, FAERS, PubChem, HMDB), разработаны алгоритмы прогнозирования магнийи пиридоксин-выводящих свойств лекарств с последующим скринингом 2527 препаратов АТХ.</p></sec><sec><title>Результаты</title><p>Результаты. Аккуратность алгоритмов в кросс-валидации составила для дефицита магния 94–98 %, для дефицита витамина B6 — 88 %. В среднем на каждый препарат приходится 8,5±6,5 антимикронутриентных эффектов. Только 4 % препаратов не проявляли негативного воздействия на микронутриентный обмен. Дефицит пиридоксина вызывают 1701 препарат (68 % от АТХ), дефицит магния — 1064 препарата (42 %). Наибольшее негативное влияние на гомеостаз обоих микронутриентов оказывают антибиотики (J01), психотропные средства (N05, N06), противоопухолевые препараты (L01), гормоны (G03), диуретики (C03), анальгетики (N02) и противовоспалительные средства (M01).</p></sec><sec><title>Заключение</title><p>Заключение. Результаты хемореактомного скрининга позволят обоснованно рекомендовать сопровождение разнообразной фармакотерапии препаратами на основе пиридоксина и органических солей магния.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Relevance</title><p>Relevance. Medicines can cause the body to lose magnesium and pyridoxine (vitamin B6), which leads to the formation of side effects and worsens the course of the underlying disease.</p></sec><sec><title>Objective</title><p>Objective. Evaluation of the antimicronutrient effect of all drugs registered in the ATX rubricator using chemoreactome screening.</p></sec><sec><title>Materials and methods</title><p>Materials and methods. Using methods of topological data analysis and labeled graph analysis, a systematic computer analysis of databases (SIDER, FAERS, PubChem, HMDB) was performed, algorithms for predicting magnesium-excreting and pyridoxine-excreting properties of drugs were developed, followed by screening of 2527 ATC drugs.</p></sec><sec><title>Results</title><p>Results. The accuracy of the algorithms in cross-validation was 94–98 % for magnesium deficiency and 88 % for vitamin B6 deficiency. On average, each drug accounts for 8.5±6.5 antimicronutrient effects. Only 4 % of drugs did not show a negative effect on micronutrient metabolism. Pyridoxine deficiency is caused by 1701 drugs (68 % of ATC), magnesium deficiency — by 1064 drugs (42 %). The most negative impact on the homeostasis of both micronutrients is exerted by antibiotics (J01), psychotropic drugs (N05, N06), antineoplastic agents (L01), hormones (G03), diuretics (C03), analgesics (N02) and antiinflammatory drugs (M01).</p></sec><sec><title>Conclusion</title><p>Conclusion. The results of chemoreactome screening will allow us to reasonably recommend accompanying various pharmacotherapy with drugs based on pyridoxine and organic magnesium salts.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>гипомагнеземия</kwd><kwd>ятрогения</kwd><kwd>дефицит пиридоксина</kwd><kwd>гиповитаминоз</kwd><kwd>большие данные</kwd><kwd>фармакоинформатика</kwd></kwd-group><kwd-group xml:lang="en"><kwd>hypomagnesemia</kwd><kwd>iatrogeny</kwd><kwd>pyridoxine deficiency</kwd><kwd>hypovitaminosis</kwd><kwd>big data</kwd><kwd>pharmacoinformatics</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Passarelli S, Free CM, Shepon A, et al. Global estimation of dietary micronutrient inadequacies: a modelling analysis. Lancet Glob Health. 2024 Oct;12(10):e1590-e1599. doi: 10.1016/S2214-109X(24)00276-6.</mixed-citation><mixed-citation xml:lang="en">Passarelli S, Free CM, Shepon A, et al. Global estimation of dietary micronutrient inadequacies: a modelling analysis. Lancet Glob Health. 2024 Oct;12(10):e1590-e1599. doi: 10.1016/S2214-109X(24)00276-6.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Wang X, Dou Z, Feng S, et al. Global food nutrients analysis reveals alarming gaps and daunting challenges. Nat Food. 2023 Nov;4(11):1007-1017. doi: 10.1038/s43016-023-00851-5.</mixed-citation><mixed-citation xml:lang="en">Wang X, Dou Z, Feng S, et al. Global food nutrients analysis reveals alarming gaps and daunting challenges. Nat Food. 2023 Nov;4(11):1007-1017. doi: 10.1038/s43016-023-00851-5.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Adomako EA, Yu ASL. Magnesium Disorders: Core Curriculum 2024. Am J Kidney Dis. 2024 Jun;83(6):803-815. doi: 10.1053/j.ajkd.2023.10.017.</mixed-citation><mixed-citation xml:lang="en">Adomako EA, Yu ASL. Magnesium Disorders: Core Curriculum 2024. Am J Kidney Dis. 2024 Jun;83(6):803-815. doi: 10.1053/j.ajkd.2023.10.017.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Shikh EV, Makhova AA, Chemeris AV, Tormyshov IA. [Iatrogenic deficits of micronutrients]. Vopr Pitan. 2021;90(4):53-63. Russian. doi: 10.33029/0042-8833-2021-90-4-53-63.</mixed-citation><mixed-citation xml:lang="en">Shikh EV, Makhova AA, Chemeris AV, Tormyshov IA. [Iatrogenic deficits of micronutrients]. Vopr Pitan. 2021;90(4):53-63. Russian. doi: 10.33029/0042-8833-2021-90-4-53-63.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Громова О.А., Торшин И.Ю., Моисеев В.С., Сорокина М.А. О фармакологических взаимодействиях магния с антибиотиками и дефиците магния, возникающем в результате антибиотикотерапии. Терапия. 2017;11(1):135-143.</mixed-citation><mixed-citation xml:lang="en">Gromova OA, Torshin IYu, Moiseev VS, Sorokina MA. On the pharmacological interactions of antibiotics with magnesium and on the magnesium deficiency arising as a result of antibiotic treatment. Therapy. 2017;11(1):135-143. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Lameris AL, Monnens LA, Bindels RJ, Hoenderop JG. Drug-induced alterations in Mg2+ homoeostasis. Clin Sci (Lond). 2012 Jul;123(1):1-14. doi: 10.1042/CS20120045.</mixed-citation><mixed-citation xml:lang="en">Lameris AL, Monnens LA, Bindels RJ, Hoenderop JG. Drug-induced alterations in Mg2+ homoeostasis. Clin Sci (Lond). 2012 Jul;123(1):1-14. doi: 10.1042/CS20120045.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Громова О.А., Торшин И.Ю., Калачева А.Г., Гришина Т.Р. О синергизме калия и магния в поддержании функции миокарда. Кардиология. 2016;56(3):73-80. doi: 10.18565/cardio.2016.3.73-80.</mixed-citation><mixed-citation xml:lang="en">Gromova OA, Torshin IYu, Kalacheva AG, Grishina TR. On synergism of potassium and magnesium in maintenance of myocardial function. Kardiologiia. 2016;56(3):73-80. (In Russ.). doi: 10.18565/cardio.2016.3.73-80.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Kuhn M, Letunic I, Jensen LJ, Bork P. The SIDER database of drugs and side effects. Nucleic Acids Res. 2016 Jan 4;44(D1):D1075-9. doi: 10.1093/nar/gkv1075.</mixed-citation><mixed-citation xml:lang="en">Kuhn M, Letunic I, Jensen LJ, Bork P. The SIDER database of drugs and side effects. Nucleic Acids Res. 2016 Jan 4;44(D1):D1075-9. doi: 10.1093/nar/gkv1075.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Торшин И.Ю., Громова О.А., Чучалин А.Г., Журавлев Ю.И. Хемореактомный скрининг воздействия фармакологических препаратов на SARS-CoV-2 и виром человека как информационная основа для принятия решений по фармакотерапии COVID-19. ФАРМАКОЭКОНОМИКА. Современная фармакоэкономика и фармакоэпидемиология. 2021;14(2):191-211. doi: 10.17749/2070-4909/farmakoekonomika.2021.078.</mixed-citation><mixed-citation xml:lang="en">Torshin IYu, Gromova ОА, Chuchalin АG, Zhuravlev YuI. Chemoreactome screening of pharmaceutical effects on SARS-CoV-2 and human virome to help decide on drug-based COVID-19 therapy. FARMAKOEKONOMIKA. Sovremennaya farmakoekonomika i farmakoepidemiologiya / FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology. (In Russ.). doi: 10.17749/2070-4909/farmakoekonomika.2021.078.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Bolton E, Wang Y, Thiessen PA, Bryant SH. Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities. Annual Reports in Computational Chemistry. 2008;4: 217-241. doi: 10.1016/S1574-1400(08)00012-1.</mixed-citation><mixed-citation xml:lang="en">Bolton E, Wang Y, Thiessen PA, Bryant SH. Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities. Annual Reports in Computational Chemistry. 2008;4: 217-241. doi: 10.1016/S1574-1400(08)00012-1.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Wishart DS, Tzur D, Knox C, et al. HMDB: the Human Metabolome Database. Nucleic Acids Res. 2007 Jan;35(Database issue):D521-6. doi: 10.1093/nar/gkl923.</mixed-citation><mixed-citation xml:lang="en">Wishart DS, Tzur D, Knox C, et al. HMDB: the Human Metabolome Database. Nucleic Acids Res. 2007 Jan;35(Database issue):D521-6. doi: 10.1093/nar/gkl923.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">von Mering C, Jensen LJ, Snel B, et al. STRING: known and predicted protein-protein associations, integrated and transferred across organisms. Nucleic Acids Res. 2005 Jan 1;33(Database issue):D433-7. doi: 10.1093/nar/gki005.</mixed-citation><mixed-citation xml:lang="en">von Mering C, Jensen LJ, Snel B, et al. STRING: known and predicted protein-protein associations, integrated and transferred across organisms. Nucleic Acids Res. 2005 Jan 1;33(Database issue):D433-7. doi: 10.1093/nar/gki005.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Torshin IYu, Rudakov KV. On the Procedures of Generation of Numerical Features over Partitions of Sets of Objects in the Problem of Predicting Numerical Target Variables. Pattern Recognit. Image Anal. 2019;29(4):654-667. doi: 10.1134/S1054661819040175.</mixed-citation><mixed-citation xml:lang="en">Torshin IYu, Rudakov KV. On the Procedures of Generation of Numerical Features over Partitions of Sets of Objects in the Problem of Predicting Numerical Target Variables. Pattern Recognit. Image Anal. 2019;29(4):654-667. doi: 10.1134/S1054661819040175.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Torshin IYu, Rudakov KV. On the application of the combinatorial theory of solvability to the analysis of chemographs. Part 1: Fundamentals of modern chemical bonding theory and the concept of the chemograph. Pattern Recognit. Image Anal. 2014;24(1):11-23. doi: 10.1134/S1054661814010209.</mixed-citation><mixed-citation xml:lang="en">Torshin IYu, Rudakov KV. On the application of the combinatorial theory of solvability to the analysis of chemographs. Part 1: Fundamentals of modern chemical bonding theory and the concept of the chemograph. Pattern Recognit. Image Anal. 2014;24(1):11-23. doi: 10.1134/S1054661814010209.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Torshin IYu, Rudakov KV. On the Application of the Combinatorial Theory of Solvability to the Analysis of Chemographs: Part 2. Local Completeness of Invariants of Chemographs in View of the Combinatorial Theory of Solvability. Pattern Recognit. Image Anal. 2014;24(2):196-208. doi: 10.1134/S1054661814020151.</mixed-citation><mixed-citation xml:lang="en">Torshin IYu, Rudakov KV. On the Application of the Combinatorial Theory of Solvability to the Analysis of Chemographs: Part 2. Local Completeness of Invariants of Chemographs in View of the Combinatorial Theory of Solvability. Pattern Recognit. Image Anal. 2014;24(2):196-208. doi: 10.1134/S1054661814020151.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Torshin IYu. The study of the solvability of the genome annotation problem on sets of elementary motifs. Pattern Recognit. Image Anal. 2011;21(4):652-662. doi: 10.1134/S1054661811040171.</mixed-citation><mixed-citation xml:lang="en">Torshin IYu. The study of the solvability of the genome annotation problem on sets of elementary motifs. Pattern Recognit. Image Anal. 2011;21(4):652-662. doi: 10.1134/S1054661811040171.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Громова О.А., Торшин И.Ю. Магний и «болезни цивилизации». Москва: ГЭОТАР-Медиа, 2018. 800 с. ISBN 978-5-9704-4527-3.</mixed-citation><mixed-citation xml:lang="en">Gromova OA, Torshin IYu. Magnesium and "Civilization Diseases". Moscow: GEOTAR-Media, 2018. (In Russ.). ISBN 978-5-9704-4527-3.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Potter E, Reyes M, Naples J, Dal Pan G. FDA Adverse Event Reporting System (FAERS) Essentials: A Guide to Understanding, Applying, and Interpreting Adverse Event Data Reported to FAERS. Clin Pharmacol Ther. 2025 Sep;118(3):567-582. doi: 10.1002/cpt.3701.</mixed-citation><mixed-citation xml:lang="en">Potter E, Reyes M, Naples J, Dal Pan G. FDA Adverse Event Reporting System (FAERS) Essentials: A Guide to Understanding, Applying, and Interpreting Adverse Event Data Reported to FAERS. Clin Pharmacol Ther. 2025 Sep;118(3):567-582. doi: 10.1002/cpt.3701.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Копицына У.Е., Гришина Т.Р., Торшин И.Ю., и др. Сверхнизкий уровень магния в эритроцитах как значимый фактор патогенеза пограничных психических расстройств. Журнал неврологии и психиатрии им. С.С. Корсакова. 2015;115(11):85 96. doi: 10.17116/jnevro201511511185-96.</mixed-citation><mixed-citation xml:lang="en">Kopitsyna UE, Grishina TR, Torshin IIu, et al. Very low magnesium levels in red blood cells as a significant factor in the etiopathogenesis of borderline disorders. S.S. Korsakov Journal of Neurology and Psychiatry. 2015;115(11):85 96. (In Russ.). doi: 10.17116/jnevro201511511185-96.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Громова О.А., Торшин И.Ю., Рудаков К.В., и др. Недостаточность магния – достоверный фактор риска коморбидных состояний: результаты крупномасштабного скрининга магниевого статуса в регионах России. Фарматека. 2013;6(259):116-129.</mixed-citation><mixed-citation xml:lang="en">Gromova OA, Torshin IYu, Rudakov KV, et al. Magnesium deficiency is a reliable risk factor of comorbid conditions: results of a large-scale screening of magnesium status in regions of Russia. Pharmatheca. 2013;6(259):116-129. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Wade RL, Chaudhari P, Natoli JL, et al. Nephrotoxicity and other adverse events among inpatients receiving liposomal amphotericin B or amphotericin B lipid complex. Diagn Microbiol Infect Dis. 2013 Jul;76(3):361-7. doi: 10.1016/j.diagmicrobio.2013.04.001.</mixed-citation><mixed-citation xml:lang="en">Wade RL, Chaudhari P, Natoli JL, et al. Nephrotoxicity and other adverse events among inpatients receiving liposomal amphotericin B or amphotericin B lipid complex. Diagn Microbiol Infect Dis. 2013 Jul;76(3):361-7. doi: 10.1016/j.diagmicrobio.2013.04.001.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Abo-Salem E, Fowler JC, Attari M, et al. Antibiotic-induced cardiac arrhythmias. Cardiovasc Ther. 2014 Feb;32(1):19-25. doi: 10.1111/1755-5922.12054.</mixed-citation><mixed-citation xml:lang="en">Abo-Salem E, Fowler JC, Attari M, et al. Antibiotic-induced cardiac arrhythmias. Cardiovasc Ther. 2014 Feb;32(1):19-25. doi: 10.1111/1755-5922.12054.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Kes P, Reiner Z. Symptomatic hypomagnesemia associated with gentamicin therapy. Magnes Trace Elem. 1990;9(1):54-60.</mixed-citation><mixed-citation xml:lang="en">Kes P, Reiner Z. Symptomatic hypomagnesemia associated with gentamicin therapy. Magnes Trace Elem. 1990;9(1):54-60.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Liamis G, Hoorn EJ, Florentin M, Milionis H. An overview of diagnosis and management of drug-induced hypomagnesemia. Pharmacol Res Perspect. 2021 Aug;9(4):e00829. doi: 10.1002/prp2.829.</mixed-citation><mixed-citation xml:lang="en">Liamis G, Hoorn EJ, Florentin M, Milionis H. An overview of diagnosis and management of drug-induced hypomagnesemia. Pharmacol Res Perspect. 2021 Aug;9(4):e00829. doi: 10.1002/prp2.829.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">von Vigier RO, Truttmann AC, Zindler-Schmocker K, et al. Aminoglycosides and renal magnesium homeostasis in humans. Nephrol Dial Transplant. 2000 Jun;15(6):822-6. doi: 10.1093/ndt/15.6.822.</mixed-citation><mixed-citation xml:lang="en">von Vigier RO, Truttmann AC, Zindler-Schmocker K, et al. Aminoglycosides and renal magnesium homeostasis in humans. Nephrol Dial Transplant. 2000 Jun;15(6):822-6. doi: 10.1093/ndt/15.6.822.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Stahlmann R, Lode H. Safety considerations of fluoroquinolones in the elderly: an update. Drugs Aging. 2010 Mar 1;27(3):193-209. doi: 10.2165/11531490-000000000-00000.</mixed-citation><mixed-citation xml:lang="en">Stahlmann R, Lode H. Safety considerations of fluoroquinolones in the elderly: an update. Drugs Aging. 2010 Mar 1;27(3):193-209. doi: 10.2165/11531490-000000000-00000.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Khow KS, Lau SY, Li JY, Yong TY. Diuretic-associated electrolyte disorders in the elderly: risk factors, impact, management and prevention. Curr Drug Saf. 2014 Mar;9(1):2-15. doi: 10.2174/1574886308666140109112730.</mixed-citation><mixed-citation xml:lang="en">Khow KS, Lau SY, Li JY, Yong TY. Diuretic-associated electrolyte disorders in the elderly: risk factors, impact, management and prevention. Curr Drug Saf. 2014 Mar;9(1):2-15. doi: 10.2174/1574886308666140109112730.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Громова О.А., Гришина Т.Р., Торшин И.Ю., и др. Прием диуретиков провоцирует дефицит магния: тактика коррекции. Терапия. 2017;2(12):122-33.</mixed-citation><mixed-citation xml:lang="en">Gromova OA, Grishina TR, Torshin IYu, et al. Diuretics induce magnesium deficiency: tactics of correction. Therapy. 2017;2(12):122-33. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Rosner MH, Ha N, Palmer BF, Perazella MA. Acquired Disorders of Hypomagnesemia. Mayo Clin Proc. 2023 Apr;98(4):581-596. doi: 10.1016/j.mayocp.2022.12.002.</mixed-citation><mixed-citation xml:lang="en">Rosner MH, Ha N, Palmer BF, Perazella MA. Acquired Disorders of Hypomagnesemia. Mayo Clin Proc. 2023 Apr;98(4):581-596. doi: 10.1016/j.mayocp.2022.12.002.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Громова О.А., Торшин И.Ю., Лиманова О.А., и др. Сравнительное исследование доказательной базы эффективности и безопасности применения пероральной и трансдермальной форм заместительной гормональной терапии эстрогенами у женщин в различные возрастные периоды. Проблемы репродукции. 2013;(6):86 96.</mixed-citation><mixed-citation xml:lang="en">Gromova OA, Torshin IYu, Limanova OA, et al. The comparative study of evidence based data concerning efficacy and safety of oral and transdermal estrogen replacement therapy in women of different age. Russian Journal of Human Reproduction. 2013;(6):86 96. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Lidegaard O. Oral contraception and risk of a cerebral thromboembolic attack: results of a case-control study. BMJ. 1993 Apr 10;306(6883):956-63. doi: 10.1136/bmj.306.6883.956.</mixed-citation><mixed-citation xml:lang="en">Lidegaard O. Oral contraception and risk of a cerebral thromboembolic attack: results of a case-control study. BMJ. 1993 Apr 10;306(6883):956-63. doi: 10.1136/bmj.306.6883.956.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Morris MS, Picciano MF, Jacques PF, Selhub J. Plasma pyridoxal 5'-phosphate in the US population: the National Health and Nutrition Examination Survey, 2003-2004. Am J Clin Nutr. 2008 May;87(5):1446-54. doi: 10.1093/ajcn/87.5.1446.</mixed-citation><mixed-citation xml:lang="en">Morris MS, Picciano MF, Jacques PF, Selhub J. Plasma pyridoxal 5'-phosphate in the US population: the National Health and Nutrition Examination Survey, 2003-2004. Am J Clin Nutr. 2008 May;87(5):1446-54. doi: 10.1093/ajcn/87.5.1446.</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Громова О.А., Торшин И.Ю., Коденцова В.М. Пищевые продукты: содержание и усвоение магния. Терапия. 2016;2(5):87-96. EDN: XCFZUJ.</mixed-citation><mixed-citation xml:lang="en">Gromova OA, Torshin IYu, Kodentsova VM. Foods: Magnesium content and uptake. Therapy. 2016;2(5):87-96. (In Russ.). EDN: XCFZUJ.</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Лебедев В.А., Пашков В.М., Буданов П.В. Клиническое значение дефицита магния у женщин с предменструальным синдромом. Вопр. гинекол., акуш. и перинатол. 2008;7(1): 77-82.</mixed-citation><mixed-citation xml:lang="en">Lebedev VA, Pashkov VM, Budanov PV. Klinicheskoe znachenie defitsita magniia u zhenshchin s predmenstrual'nym sindromom. Vopr. ginekol., akush. i perinatol. 2008;7(1):77-82. (In Russ.)</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
